ANRO as of Oct 31 · 07:50 ET
ANRONYSEPharmaceutical Preparations

Alto Neuroscience, Inc. · Brief

Next report

11 days

Nov 11 · before openest.Q3 FY26

Expected move

Inputs

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±13.6%▲+10.69%×0.79
quarterimplied−15%0+15%realized×
Q2 FY26±13.6%▲+10.69%×0.79
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2 of 3

10disclosed supplier and customer tiesSEC filings
116managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

8 of 24largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
20managers holding most of reported value13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

ANRO report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±19.1% into Nov 11 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.